PERISOC, solution de cardioplégie/solution pour conservation dorgane

solution cardioplégique ou · intracoronaire / voie extracorporelle autre

Directory source checks passedOriginal source language: French

Source data retrieved: 2026-09-17. Clinical review is not yet available.

Formsolution cardioplégique ou

Routeintracoronaire / voie extracorporelle autre

Ingredient entries9

CountryFrance

Product identity

At a glance

Authorisation holder: DR. FRANZ KÖHLER CHEMIE (ALLEMAGNE)
Authorisation status: Autorisation active
Market status: Commercialisée
Country: France
Source reference: CIS 68491709

Reported market status does not confirm current pharmacy stock.

From the official composition record

Ingredients & strength

Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.

Source composition entries for PERISOC, solution de cardioplégie/solution pour conservation dorgane
Ingredient	Strength / reference	Source role
CHLORURE DE POTASSIUMsolution	0,6710 g1000 mL de solution	SAGroup 2
CHLORURE DE CALCIUM DIHYDRATÉsolution	0,0022 g1000 mL de solution	SAGroup 4
HISTIDINEsolution	27,9289 g1000 mL de solution	SAGroup 5
TRYPTOPHANE Lsolution	0,4085 g g1000 mL de solution	SAGroup 7
CHLORURE DE SODIUMsolution	0,8766 g1000 mL de solution	SAGroup 1
MANNITOLsolution	5,4651 g1000 mL de solution	SAGroup 8
CHLORURE DE MAGNÉSIUM HEXAHYDRATÉsolution	0,8132 g1000 mL de solution	SAGroup 3
CHLORHYDRATE D'HISTIDINE MONOHYDRATÉsolution	3,7733 g1000 mL de solution	SAGroup 6
ACIDE ALPHA-CÉTOGLUTARIQUEsolution	0,1461 g1000 mL de solution	SAGroup 9

Pack references

Presentations (2)

6 poche(s) en plastique de 1000 ml

CIP13 3400955071211

Présentation active · Déclaration de commercialisation

4 poche(s) en plastique de 2000 ml

CIP13 3400955071228

Présentation active · Déclaration de commercialisation

From the French medicines authority

Official documents

The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.

Open the official product entryBDPM · CIS 68491709 · Opens in a new tab

Check the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.

Where this information comes from

Sources & dates

Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.

Source files and their retrieval dates
Source file	Retrieved	Source file modified
fr_products.txt	2026-09-17	Not supplied
fr_composition.txt	2026-09-17	Not supplied
fr_packs.txt	2026-09-17	Not supplied

Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.

Our sources and review process →